LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 35 filers reported holding LOXO ONCOLOGY INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $2,228,000 | -26.6% | 24,188 | -36.1% | 0.01% | -25.0% |
| Q2 2017 | $3,035,000 | +163.0% | 37,849 | +38.0% | 0.01% | +140.0% |
| Q1 2017 | $1,154,000 | +72.8% | 27,434 | +31.9% | 0.01% | +66.7% |
| Q4 2016 | $668,000 | +16.6% | 20,802 | -5.0% | 0.00% | +50.0% |
| Q3 2016 | $573,000 | +5.7% | 21,892 | -6.4% | 0.00% | 0.0% |
| Q2 2016 | $542,000 | +251.9% | 23,392 | +316.5% | 0.00% | +100.0% |
| Q1 2016 | $154,000 | -4.3% | 5,617 | -0.5% | 0.00% | 0.0% |
| Q4 2015 | $161,000 | -38.3% | 5,644 | -62.3% | 0.00% | 0.0% |
| Q3 2015 | $261,000 | -3.3% | 14,958 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $270,000 | +73.1% | 14,958 | +19.2% | 0.00% | 0.0% |
| Q1 2015 | $156,000 | +6.1% | 12,553 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $147,000 | +56.4% | 12,553 | +76.2% | 0.00% | – |
| Q3 2014 | $94,000 | – | 7,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital LLC | 2,038,920 | $285,592,000 | 80.87% |
| DAFNA Capital Management LLC | 181,675 | $25,447,000 | 12.65% |
| Opaleye Management Inc. | 175,000 | $24,512,000 | 9.15% |
| Casdin Capital, LLC | 360,000 | $50,425,000 | 8.63% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 21,775 | $3,050,000 | 3.58% |
| Avoro Capital Advisors LLC | 325,000 | $45,523,000 | 2.72% |
| AWM Investment Company, Inc. | 70,000 | $9,805,000 | 2.13% |
| Opus Point Partners Management, LLC | 6,210 | $870,000 | 1.92% |
| Eventide Asset Management | 274,000 | $38,379,000 | 1.70% |
| Aquilo Capital Management, LLC | 24,750 | $3,467,000 | 1.68% |